I did add Pfizer, symbol PFE to the 2017 portfolio today at a basis of $33.797. The same amount invested in SDY bought 38.08756 shares at $88.735 and VIG bought 37.4332 shares at $90.31.
In 2013 I profiled AstraZeneca (AZN) as a Dividend Machine. At that time the cost basis was about $54. My personal basis is about $46. Today, Pfizer (PFE) is making a bid to buy AZN and the results is AZN is up over $10. AZN is no longer a Dividend Machine because of falling revenues that have caused EPS (earnings per share) to fall below their dividend payout. All of you know that EPS must exceed dividends for a stock to be considered a Dividend Machine.
Deciding if you should sell a dividend machine is an interesting question; a question I faced this last week. Today, I want to compare two dividend machines in the same industry and use them as an exercise in how to determine if you should sell a dividend machine based on bad news.
I am an income investor: I invest in and write about income from Dividend Stocks, covered call options, and now after a long time, laddered bonds including CD's and treasuries.